首页> 外国专利> INHALABLE AZTREONAM FOR USE IN THE TREATMENT OF PULMONARY INFECTIONS CAUSED BY GRAM NEGATIVE BACTERIA AND FORMULATIONS AND PRODUCTS COMPRISING THE SAME

INHALABLE AZTREONAM FOR USE IN THE TREATMENT OF PULMONARY INFECTIONS CAUSED BY GRAM NEGATIVE BACTERIA AND FORMULATIONS AND PRODUCTS COMPRISING THE SAME

机译:吸入性氨氮酮用于治疗革兰氏阴性细菌及其组成的配方和产品引起的肺部感染

摘要

A method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of infection caused by Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenzae, Proteus mirabilis, Enterobacter species, Serratia marcescens as well as those caused by Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, and multidrug resistant Pseudomonas aeruginosa, using a concentrated formulation of aztreonam, or a pharmaceutically acceptable salt thereof, delivered as an aerosol or dry powder formulation.
机译:用于治疗由革兰氏阴性细菌引起的肺部细菌感染的方法和组合物,所述方法和组合物适合于治疗由大肠杆菌,肺炎克雷伯氏菌,产酸克雷伯菌,铜绿假单胞菌,流感嗜血杆菌,变形杆菌,肠杆菌,肠粘菌,沙雷氏菌以及由洋葱伯克霍尔德氏菌,嗜麦芽窄食单胞菌,木生拟南芥和多药耐药性铜绿假单胞菌引起的那些,使用氨曲南的浓缩制剂或其药学上可接受的盐,以气雾剂或干粉制剂形式提供。

著录项

  • 公开/公告号IL156596B

    专利类型

  • 公开/公告日2012-07-31

    原文格式PDF

  • 申请/专利权人 GILEAD SCIENCES INC.;SALUS PHARMA INC.;

    申请/专利号IL156596

  • 发明设计人

    申请日2003-06-23

  • 分类号

  • 国家 IL

  • 入库时间 2022-08-21 17:24:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号